Relationship expert teams up with Pfizer to address intimacy and relationship issues for people living with chronic diseases

PfizerNationally-recognized relationship expert and author, Logan Levkoff, Ph.D., has partnered with Pfizer Inc. (NYSE:PFE) to fill a void in information available to people living with chronic diseases: relationship advice. Levkoff will address the topics of relationships and intimacy for those living with a chronic condition, like rheumatoid arthritis (RA), on the newly re-launched Arthritis.com site. The website is a place where people living with a chronic illness can find inspiration, lifestyle advice, tools, and disease information. While many Americans struggle with these issues, Pfizer has heard from some members of the RA community that they can be particularly challenging for those living with chronicdiseases such as RA, and that information hasn't been widely available for this community until now.

"I'm thrilled to be partnering with Pfizer on Arthritis.com to help provide insight on dealing with tough issues including self-love, dating and communicating with partners, which may be particularly difficult for people living with a chronic condition." These topics can be difficult for people living with a chronic condition, like RA, to face head-on as part of their day-to-day lives. In fact, one small study using self-administered questionnaires with those living with RA (n=57) revealed that more than half feel that their disease places limitations on intimacy and more than a third say that living with RA has strained their relationship with their partner.(1)

"People living with RA have a lot to cover and discuss during doctor visits. Having a support system and educational resources are important when managing the disease," says Ara Dikranian, MD, Rheumatologist, Cabrillo Center for Rheumatic Disease. "Arthritis.com will help bring to light topics that may not have been discussed in-depth, and the content encourages people to take action and speak with their healthcare provider about ways to manage their condition beyond just treating symptoms."

As part of its commitment helping to improve the lives of people living with arthritis by providing education and awareness, Pfizer will continue to roll out new resources on Arthritis.com, focusing on under-addressed topics. "We know that many of the millions of people suffering from rheumatoid arthritis(2,3) are struggling with more than just the physical symptoms of the disease," says Angela Hwang, Global President Inflammation and Immunology at Pfizer. "We are developing resources like Arthritis.com to help provide information on topics that go beyond medicine. We are committed to supporting the overall wellbeing of people with RA."

About Arthritis.com
Arthritis.com is Pfizer's newly updated support site where people can find inspiration, advice, tools and disease information to help manage RA in daily life. In addition to articles on love, relationships, dating and financial advice, the website also offers information on exercise, nutrition, parenting, and spirituality. Techniques on how to set treatment goals are also available via the website.

About Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disease that causes a range of symptoms, including stiffness and swelling in the joints,(4,5) particularly those in the hands, feet and knees.(3) Although the exact cause of RA is unknown,(3) it is considered to be an autoimmune disease, because the immune system in people with RA mistakes the body's healthy tissues as a threat and attacks them.(3) Some people are at increased risk of developing RA, including people with a family history of RA, smokers and women.(6) Three times as many women are affected by RA compared to men.(3) Approximately 1.6 million Americans are trying to manage symptoms of RA.(7,8) It can develop at any time during adulthood, but it usually occurs between 40 and 70 years of age.(2)

About Osteoarthritis
Osteoarthritis (OA) is a chronic condition characterized by the breakdown of joint cartilage.(9) OA is the most common form of arthritis.(9) While the cause of OA is unknown, it occurs when cartilage breaks down in the joints over time. OA can occur in any joint, but is the most common in the knees, hips, hands, and spine. OA affects nearly 27 million adults in the U.S.,(9) and is the most common of all types of arthritis in the U.S.(9) About 1 in 2 people in the U.S. will experience OA of the knee in their lifetime.

Pfizer Inc.: Working together for a healthier world™
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer healthcare products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

1. Hill J, Bird H, Thorpe R. Effects of rheumatoid arthritis on sexual activity and relationships. Rheumatology. 2003;42(2):280-286.
2. Sacks JJ, Luo YH, Helmick CG. Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001-2005. Arthritis Care Res (Hoboken). 2010;62(4):460-464.
3. Howden L, Meyer J. 2010 U.S. Census Bureau results - U.S. Census Bureau, 2010 Census Summary File 1. 4. Medline Plus. "Rheumatoid Arthritis" Accessed 22 August 2016. Available at http://www.nlm.nih.gov/medlineplus/ency/article/000431.htm
5. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358:903-911.
6. Mayo Clinic. "Rheumatoid Arthritis. Symptoms and causes" Accessed 22 August 2016. Available at http://www.mayoclinic.org/diseases-conditions/rheumatoid-arthritis/symptoms-causes/dxc-20197390
7. Sacks JJ, Luo YH, Helmick CG. Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001-2005. Arthritis Care Res (Hoboken). 2010;62(4):460-464.
8. Howden L, Meyer J. 2010 U.S. Census Bureau results - U.S. Census Bureau, 2010 Census Summary File 1.
9 National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Handout on health: osteoarthritis. Updated April 2015. Accessed August 10, 2016. Available at http://www.niams.nih.gov/Health_Info/Osteoarthritis/

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

The origin-of-life molecule, a key to cancer resea…

RNA, the molecule that gave rise to life, has been shown to be essential for repairing human genetic material and preventing mutations that might lead to developing cance...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...